Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(8%)
Results Posted
0%(0 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_4
4
33%
Ph not_applicable
3
25%
Ph phase_2
1
8%
Ph phase_1
2
17%
Ph phase_3
1
8%

Phase Distribution

2

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 44 (36.4%)
N/A3 (27.3%)

Trials by Status

completed867%
not_yet_recruiting18%
terminated217%
recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
not_yet_recruitingphase_3

Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management

NCT07682558
recruitingnot_applicable

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

NCT07384013
completedphase_4

TAP vs QLB in Patients After Cesarean Delivery

NCT03404908
completednot_applicable

Evaluation of the Added Value of Metamizole to Standard Postoperative Treatment After Ambulant Shoulder Surgery

NCT04703257
completedphase_4

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

NCT04691726
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07682558Phase 3

Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management

Not Yet Recruiting
NCT07384013Not Applicable

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Recruiting
NCT03404908Phase 4

TAP vs QLB in Patients After Cesarean Delivery

Completed
NCT04703257Not Applicable

Evaluation of the Added Value of Metamizole to Standard Postoperative Treatment After Ambulant Shoulder Surgery

Completed
NCT04691726Phase 4

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

Completed
NCT04082728Not Applicable

Evaluation of the Added Value of Metamizole to Standard Post-operative Treatment After Ambulant Surgery

Completed
NCT04720248

Postoperative Pain in Scheduled Craniotomy

Completed
NCT03990129Phase 1

Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects

Completed
NCT02660177Phase 2

Pharmacokinetics of Intravenous Metamizole in Children Less Than 6 Years Old

Completed
NCT01995006Phase 1

Effect of Metamizole (Dipyrone) on Renal Function in Salt-depleted Healthy Subjects

Completed
NCT02181920Phase 4

Metamizol for the Treatment of Neoplastic Chronic Pain

Terminated
NCT02184260Phase 4

Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke

Terminated

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12